Presentation and outcome of tuberculous meningitis in a high HIV prevalence setting

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Marais, Suzaan ^a,b   Pepper, Dominique J ^a,c   Schutz, Charlotte ^a,b   Wilkinson, Robert J ^a,b,d,e   Meintjes, Graeme ^a,b,d  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b GF Jooste Hospital   (South Africa)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ; ETHAMBUTOL; ISONIAZID; LAMIVUDINE; NEVIRAPINE; PYRAZINAMIDE; RIFAMPICIN; STAVUDINE; STREPTOMYCIN;

ADULT; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID ANALYSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MIXED INFECTION; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; RETROSPECTIVE STUDY; REVIEW; TUBERCULOSIS; TUBERCULOUS MENINGITIS; AIDS RELATED COMPLEX; ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; SOUTH AFRICA;

MYCOBACTERIUM TUBERCULOSIS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; HIV SEROPREVALENCE; HUMANS; RETROSPECTIVE STUDIES; SOUTH AFRICA; TUBERCULOSIS, MENINGEAL;

EID: 79956267316     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020077     Document Type: Review

References (33)

1. Bekondi C, Bernede C, Passone N, Minssart P, Kamalo C, et al. (2006) Primary and opportunistic pathogens associated with meningitis in adults in Bangui, Central African Republic, in relation to human immunodeficiency virus serostatus. Int J Infect Dis 10: 387-95.
2. Gordon SB, Walsh AL, Chaponda M, Gordon MA, Soko D, et al. (2000) Bacterial meningitis in Malawian adults: pneumococcal disease is common, severe, and seasonal. Clin Infect Dis 31: 53-7.
3. Jarvis JN, Meintjes G, Williams A, Brown Y, Crede T, et al. (2010) Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases. BMC Infect Dis 10: 67.
4. Subsai K, Kanoksri S, Siwaporn C, Helen L, (2004) Neurological complications in AIDS patients: the 1-year retrospective study in Chiang Mai University, Thailand. Eur J Neurol 11: 755-9.
5. World Health Organization: Towards universal access: scaling up priority HIV/AIDS interventions in the health sector progress report (2010) Available: http://whqlibdoc.who.int/publications/2010/9789241500395_eng.pdf Accessed 2010 Dec 2.
6. Dean GL, Edwards SG, Ives NJ, Matthews G, Fox EF, et al. (2002) Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy. AIDS 16: 75-83.
7. Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, et al. (2010) Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med 362: 697-706.
8. Croda MG, Vidal JE, Hernandez AV, Molin TD, Gualberto FA, et al. (2010) Tuberculous meningitis in HIV-infected patients in Brazil: clinical and laboratory characteristics and factors associated with mortality. Int J Infect Dis 14 (7): e586-91.
9. Torok ME, Yen NTB, Chau TTH, et al. (2010) Randomised controlled trial of immediate versus deferred antiretroviral therapy in HIV-associated tuberculosis meningitis. Clin Infect Dis In press.
10. Torok ME, Chau TT, Mai PP, Phong ND, Dung NT, et al. (2008) Clinical and microbiological features of HIV-associated tuberculous meningitis in Vietnamese adults. PLoS One 3: e1772.
11. Médecins Sans Frontières, Western Cape Province Department of Health, City of Cape Town Department of Health, University of Cape Town Infectious Disease Epidemiology Unit. Comprehensive TB/HIV Services at primary healthcare level, Khayelitsha Annual Activity Report: 2007-2008 (2008) Available: http://www.msf.or.jp/info/pressreport/pdf/2009_hiv01.pdf. Accessed 2010 July 7.
12. Gibbon CJ, Blockman M, eds. Antimycobacterials South African Medicines Formulary. 8th ed Cape Town The Division of Clinical Pharmacology, Faculty of Health Sciences, University of Cape Town pp. 301-302 2008.
13. South African Department of Health HIV-1 and AIDS and STI strategic plan for South Africa 2007-2011 (2007) Available: http://www.info.gov.za/otherdocs/2007/aidsplan2007/index.html Accessed 2010 Sept 15.
14. Thwaites GE, Duc Bang N, Huy Dung N, Thi Quy H, Thi Tuong Oanh D, et al. (2005) The influence of HIV infection on clinical presentation, response to treatment, and outcome in adults with Tuberculous meningitis. J Infect Dis 192: 2134-41.
15. British Medical Research Council (1948) Streptomycin treatment of tuberculous meningitis. BMJ 1: 582-97.
16. Heyderman RS, Gangaidzo IT, Hakim JG, Mielke J, Taziwa A, et al. (1998) Cryptococcal meningitis in human immunodeficiency virus-infected patients in Harare, Zimbabwe. Clin Infect Dis 26: 284-9.
17. Bogaerts J, Rouvroy D, Taelman H, Kagame A, Aziz MA, et al. (1999) AIDS-associated cryptococcal meningitis in Rwanda (1983-1992): epidemiologic and diagnostic features. J Infect 39: 32-7.
18. Cecchini D, Ambrosioni J, Brezzo C, Corti M, Rybko A, et al. (2007) Tuberculous meningitis in HIV-infected patients: drug susceptibility and clinical outcome. AIDS 21: 373-4.
19. Schutte CM, (2001) Clinical, cerebrospinal fluid and pathological findings and outcomes in HIV-positive and HIV-negative patients with tuberculous meningitis. Infection 29: 213-7.
20. Hosoglu S, Geyik MF, Balik I, Aygen B, Erol S, et al. (2002) Predictors of outcome in patients with tuberculous meningitis. Int J Tuberc Lung Dis 6: 64-70.
21. Thwaites GE, Nguyen DB, Nguyen HD, Hoang TQ, Do TT, Nguyen TC, et al. (2004) Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 351: 1741-51.
22. Berenguer J, Moreno S, Laguna F, Vicente T, Adrados M, et al. (1992) Tuberculous meningitis in patients infected with the human immunodeficiency virus. N Engl J Med 326: 668-72.
23. Karstaedt AS, Valtchanova S, Barriere R, Crewe-Brown HH, (1998) Tuberculous meningitis in South African urban adults. QJM 91: 743-7.
24. Marais S, Pepper DJ, Marais BJ, Torok ME, (2010) HIV-associated tuberculous meningitis- diagnostic and therapeutic challenges. Tuberculosis (Edinb) 90: 367-74.
25. Karande S, Gupta V, Kulkarni M, Joshi A, Rele M, (2005) Tuberculous meningitis and HIV. Indian J Pediatr 72: 755-60.
26. Dube MP, Holtom PD, Larsen RA, (1992) Tuberculous meningitis in patients with and without human immunodeficiency virus infection. Am J Med 93: 520-4.
27. van Well GT, Paes BF, Terwee CB, Springer P, Roord JJ, et al. (2009) Twenty years of pediatric tuberculous meningitis: a retrospective cohort study in the western cape of South Africa. Pediatrics 123: e1-8.
28. Katrak SM, Shembalkar PK, Bijwe SR, Bhandarkar LD, (2000) The clinical, radiological and pathological profile of tuberculous meningitis in patients with and without human immunodeficiency virus infection. J Neurol Sci 181: 118-26.
29. van der Weert EM, Hartgers NM, Schaaf HS, Eley BS, Pitcher RD, et al. (2006) Comparison of diagnostic criteria of tuberculous meningitis in human immunodeficiency virus-infected and uninfected children. Pediatr Infect Dis J 25: 65-9.
30. Pepper DJ, Marais S, Wilkinson RJ, Bhaijee F, Maartens G, et al. (2010) Clinical deterioration during antituberculosis treatment in Africa: Incidence, causes and risk factors. BMC Infect Dis 10: 83.
31. Pepper DJ, Marais S, Maartens G, Rebe K, Morroni C, et al. (2009) Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: A case series. Clin infect Dis 48: e96-107.
32. Price RW, Spudich S, (2008) Antiretroviral therapy and central nervous system HIV type 1 infection. J Infect Dis 197 (Suppl 3): S294-306.
33. Puccioni-Sohler M, Brandao CO, (2007) Factors associated to the positive cerebrospinal fluid culture in the tuberculous meningitis. Arq Neuropsiquiatr 65: 48-53.